Martin EJ, et al. Measuring diversity: experimental design of combinatorial libraries for drug discovery. J Med Chem1995; 38: 1431-1436.
2.
Wilkes MF, et al. Biological monitoring for pesticide exposure-the role of human volunteer studies. Int Arch Occup Environ Health1993; 65: S189-192.
3.
Blaauboer BJ , et al. The use of biokinetics and in vitro methods in toxicological risk evaluation. ATLA1996; 24: 473 -497.
4.
Clewell HJ, Andersen MEPhysiologically-based pharmacokinetic modeling and bioactivation of xenobiotics . Toxicol Ind Health1994; 10: 1-24.
5.
Droz POPharmacokinetic modeling as a tool for biological monitoring. Int Arch Occup Environ Health1993; 65: S53-9.
6.
Leung HWDevelopment and utilization of physiologically based pharmacokinetic models for toxicological applications. J Toxicol Environ Health1991; 32: 247-267.
7.
Leung HWUse of physiologically based pharmacokinetic models to establish biological exposure indexes. Am Ind Hyg Assoc J1992 ; 53: 369-374.
8.
Martonen TBMathematical model for the selective deposition of inhaled pharmaceuticals . J Pharm Sci1993; 82: 1191-1199.
9.
Martonen TB, Yang Y., Hwang D., Fleming JSMapping the human lung using Delaunay tessellation. Comput Biomed Res1994; 27: 245-262.
10.
Chiou WLEffect of 'unstirred' water layer in the intestine on the rate and extent of absorption after oral administration. Biopharm Drug Dispos1994a; 15: 709 -717.
11.
ChiouWl. Determination of drug permeability in a flat or distended stirred intestine. Prediction of fraction dose absorbed in humans after oral administration . Int J Clin Pharmacol Ther1994; 32: 474-482.
12.
Wils P., Warnery A., Phung Ba V, Scherman D. Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs. Cell Biol Toxicol1994; 10: 393-397.
13.
Alcorn CJ, Simpson RJ, Leahy D., Peters TJIn vitro studies of intestinal drug absorption. Determination of partition and distribution coefficients with brush border membrane vesicles. Biochem Pharmacol1991; 42: 2259 - 2264.
14.
Ma TY, et al. IEC-18, a nontransformed small intestinal cell line for studying epithelial permeability. J Lab Clin Med1992 ; 120: 329-341.
15.
McMenamy RH. Binding studies by dialysis equilibrium. A description of an accurate and rapid technique. Anal Biochem1968; 23: 122-128.
16.
Schuhmann G. , Fichtl B., Kurz H.Prediction of drug distribution in vivo on the basis of in vitro binding data. Biopharm Drug Dispos1987; 8: 73-86.
17.
Paterson S. , Mackay D.Correlation of tissue, blood, and air partition coefficients of volatile organic chemicals. Br J Ind Med1989; 46: 321-328.
18.
Roth WL, Weber LW, Rozman KKIncorporation of first-order uptake rate constants from simple mammillary models into blood-flow limited physiological pharmacokinetic models via extraction efficiencies. Pharm Res1995; 12: 263-269.
19.
Skett P., Tyson C., Guillouzo A., Maier P.Report on the international workshop on the use of human in vitro liver preparations to study drug metabolism in drug development. Held at Utrecht, The Netherlands, 6-8 September 1994. Biochem Pharmacol1995; 50: 280-285.
20.
Padgham CR, Paine AJAltered expression of cytochrome P-450 mRNAs, and potentially of other transcripts encoding key hepatic functions, are triggered during the isolation of rat hepatocytes. Biochem J1993; 289: 621-624.
21.
MacDonald C., et al. Expression of liver functions in immortalised rat hepatocyte cell lines. Hum Exp Toxicol1994; 13: 439-444.
22.
Ratanasavanh D., Baffet G., Latinier MF, Rissel M., Guillouzo A.Use of hepatocyte co-cultures in the assessment of drug toxicity from chronic exposure. Xenobiotica1988; 18: 765 -771.
23.
Diener B., et al. Gap junctional intercellular communication of cultured rat liver parenchymal cells is stabilized by epithelial cells and their isolated plasma membranes. Experientia1994; 50: 124-126.
24.
Crespi CL, Lagenbach R., Penman BWHuman cell lines, derived from AHH-1 TK+/- human lymphoblasts, genetically engineered for expression of cytochromes P450. Toxicology1993; 82: 89-104.
25.
Simula AP, et al. Heterologous expression of drug-metabolizing enzymes in cellular and whole animal models. Toxicology1993; 82: 3-20.
26.
Boobis ARPredicting specificity of drug metabolism using recombinant expressed enzyme systems. In: COST B1 Conference on Variability and Specificity in Drug Metabolism (Alván G, Balant LP, Bechtel PR, Boobis AR, Gram LF, Paintaud G and Pithan K, eds). European Commission, Luxembourg, pp. 57 - 73, 1995.
27.
Koymans LM, Vermeulen NP, Baarslag A., Donne Op den Kelder GM. A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building. J Comput Aided Mol Des1993; 7: 281-289.
28.
Smith DADesign of drugs through a consideration of drug metabolism and pharmacokinetics . Eur J Drug Metab Pharmacokinet1994; 19: 193 - 199.
29.
Wrighton SARing BJ, Van den Branden M.The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies . Toxicol Pathol1995; 23: 199 -208.
30.
Fleck C., Braunlich H.Factors determining the relationship between renal and hepatic excretion of xenobiotics. Arzneimittelforschung1990 ; 40: 942 -946.
31.
Boom SP, Gribnau FW, Russel FGOrganic cation transport and cationic drug interactions in freshly isolated proximal tubular cells of the rat. J Pharmacol Exp Ther1992; 263: 445-450.
32.
Williams PDThe application of renal cells in culture in studying drug-induced nephrotoxicity. In Vitro Cell Dev Biol1989; 25: 800-805.
33.
Shimamura H. , et al. Multiple systems for the biliary excretion of organic anions in rats: liquiritigenin conjugates as model compounds. J Pharmacol Exp Ther1994; 271: 370-378.
34.
Boyer JL, Gautam A., Graf J.Mechanisms of bile secretion: insights from the isolated rat hepatocyte couplet. Semin Liver Dis1988; 8: 308-316.
35.
Kawai R., et al. Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125. J Pharmacokinet Biopharm (1994) 22: 327-365.
36.
Fiserova-Bergerova V.Extrapolation of physiological parameters for physiologically based stimulation models. Toxicol Lett1995; 79: 77-86.
37.
Oesch F., Diener B.Cell systems for use in studies on the relationship between foreign compound metabolism and toxicity. Pharmacol Toxicol1995; 76: 325-327.
38.
Hawksworth GMAdvantages and disadvantages of using human cells for pharmacological and toxicological studies. Hum Exp Toxicol1994; 13: 568-573.
Osborne R., Perkins MAAn approach for development of alternative test methods based on mechanisms of skin irritation. Food Chem Toxicol1994 ; 32: 133-142.
41.
Crumb WJJr, et al. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity. Mol Pharmacol1995; 47: 181-190.
42.
Steinberger A., Klinefelter G.Sensitivity of Sertoli and Leydig cells to xenobiotics in in vitro models. Reprod Toxicol1993; 7 (Suppl 1:) 23-37.
43.
Schaefer BM , Stark HJ, Fusenig NE, Todd RF3rd, Kramer MD. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of kertinocytes in an organotypic coculture system. Exp Cell Res1995; 220: 415-423.
44.
Kane RE, Tector J., Brems JJ, Li A., Kaminski D.Sulfation and glucuronidation of acetaminophen by cultured hepatocytes reproducing in vivo sex-differences in conjugation on Matrigel and type 1 collagen. In Vitro Cell Dev Biol1991; 27A953-960.
45.
Kane RE, Li AP, Kaminski DRSulfation and glucuronidation of acetaminophen by human hepatocytes cultured on Matrigel and type 1 collagen reproduces conjugation in vivo. Drug Metab Dispos1995; 23: 303 - 307.
46.
Miller MG, et al. Predictive value of liver slices for metabolism and toxicity in vivo: use of acetaminophen as a model hepatotoxicant. Sulfation and glucuronidation of acetaminophen by cultured hepatocytes reproducing in vivo sex-differences in conjunction on Matrigel and type 1 collagen. Toxicol Appl Pharmacol1991; 27A953-960.
47.
Tee LB, Davies DS, Seddon CE, Boobis ARSpecies differences in the hepatotoxicity of paracetamol are due to differences in the rate of conversion to its cytotoxic metabolite. Biochem Pharmacol1987; 36: 1041-1052.
48.
Raucy JL, Lasker JM, Lieber CS, Black M.Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys1989; 271: 270-283.
49.
Thummel KE, et al. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol1993; 45: 1563-1569.
50.
Blair IA, Boobis AR, Davies DS, Cresp TMParacetamol oxidation: Synthesis and reactivity of N-acetyl-p-benzoquinoneimine . Toxicol. Lett1981; 21: 4947-4950.
51.
Murray GI, et al. Cytochrome P-450 localization in normal human adult and foetal liver by immunocytochemistry using a monoclonal antibody against human cytochrome P-450. Histochem J1987; 19: 537-545.
52.
McKinnon RA , et al. Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridization . Hepatology1991; 14: 848-856.
Morris ME, Levy G.Renal clearance and serum protein binding of acetaminophen and its major conjugates in humans. J Pharm Sci1984; 73: 1038-1041.
55.
Salmon SE, et al. One bead, one chemical compound: use of the selectide process for anticancer drug discovery. Acta Oncol1994; 33: 127-131.
56.
Bronson DD, et al. Virtual kinetics: using statistical experimental design for rapid analysis of enzyme inhibitor mechanisms. Flexible matching of test ligands to a 3D pharmacophore using a molecular superposition force field: comparison of predicted and experimental conformations of inhibitors of three enzymes. Biochem Pharmacol1995; 9: 237-250.
57.
Kleinberg ML , Wanke LANew approaches and technologies in drug design and discovery. Am J Health Syst Pharm1995 ; 52: 1323-1336.
58.
Ortiz AR, Pisabarro MT, Gago F., Wade RCPrediction of drug binding affinities by comparative binding energy analysis . J Med Chem1995; 38: 2681-2691.
59.
McMartin C. , Bohacek RSFlexible matching of test ligands to a 3D pharmacophore using a molecular superposition force field: comparison of predicted and experimental conformations of inhibitors of three enzymes . J Comput Aided Mol Des1995; 9: 237-250.